EUCTR2018-001034-18-IT进行中（未招募）1 期
Phase II monocentric study to evaluate a novel approach for staging prostate cancer patients by using a fully integrated hybrid PET/MRI - PETMR-Staging-PCa1
OSPEDALE SAN RAFFAELE0 个研究点目标入组 50 人开始时间: 2018年11月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •1. Age = 18 years
- •2. Diagnosis of prostate cancer proven by biopsy
- •3. Informed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 25
排除标准
- •1. Age less than 18 years
- •2. Inability to complete required imaging tests (eg severe claustrophobia)
- •3. Any other medical condition that may interfere with study compliance
- •4. All contraindications for MRI (eg pace-maker)
- •5. Evidence of metastatic disease to conventional imaging that would contraindicate the surgical procedure
研究者
相似试验
招募中
1 期
Study with Various Immunotherapy Treatments in Participants With Lung CancerAdvanced Non-Small Cell Lung CancerCTIS2022-502916-35-01Arcus Biosciences Inc.263
进行中（未招募）
不适用
A proof-of-concept Phase II study to evaluate efficacy, safety and pharmacokinetics of 4SC-201 and the treatment combination of Sorafenib plus 4SC-201 in patients with hepatocellular carcinoma exhibiting progressive disease under Sorafenib treatmentHepatocellular carcinoma non-resectableMedDRA version: 14.1Level: PTClassification code 10019695Term: Hepatic neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-010760-42-IT4SC AG74
进行中（未招募）
不适用
Proof-of-concept phase II study to evaluate the anti-tumoractivity of sorafenib along with pathological and molecularchanges in tumor samples from patientswith resectable hepatocellular carcinoma. - BIOSHAREHepatocellular carcinoma resectableMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2009-018058-44-FRGERCOR
进行中（未招募）
1 期
Study in healthy adults to evaluate gene activation after vaccination with GlaxoSmithKline (GSK) Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342Healthy volunteers (Prevention of tuberculosis [TB] disease in children, adolescents and adults)EUCTR2012-002541-37-BEGlaxoSmithKline Biologicals
进行中（未招募）
不适用
A Phase 2a, Open-label, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects with Epileptic SeizuresRecurrent Acute Repetitive Seizures (ARS)MedDRA version: 9.1Level: LLTClassification code 10039910Term: SeizuresEUCTR2007-003307-13-FIJazz Pharmaceuticals, Inc.45